ENLV
Enlivex Therapeutics Ltd.
$1.08
+$0.03(+2.86%)
49
Overall
--
Value
75
Tech
23
Quality
Market Cap
$232.63M
Volume
534.92K
52W Range
$0.66 - $2.10
Target Price
$13.00
EPS Estimates Overview
| Current Quarter | $-0.03 | Next Quarter | $-0.01 |
| Current Year | $-0.21 | Next Year | $-0.05 |
| QoQ Growth | +66.7% | YoY Growth | +76.2% |
| 3Y EPS CAGR | N/A | Target Price | $13.00 |
| Consensus | Buy | Upside | +1103.7% |
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ENLV | $1.08 | +2.9% | 534.92K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Enlivex Therapeutics Ltd. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW